205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
134.01%
Some net income increase while MCHP is negative at -17.44%. John Neff would see a short-term edge over the struggling competitor.
-12.00%
Negative yoy D&A while MCHP is 2.94%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-112.38%
Negative yoy deferred tax while MCHP stands at 80.86%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-262.81%
Both reduce yoy usage, with MCHP at -83.12%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-378.79%
Both reduce yoy inventory, with MCHP at -153.78%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-122.29%
Both reduce yoy usage, with MCHP at -78.80%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-88.30%
Negative yoy while MCHP is 483.18%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-73.66%
Negative yoy CFO while MCHP is 5.89%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
44.07%
Some CapEx rise while MCHP is negative at -199.58%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-39.68%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
318.88%
Liquidation growth of 318.88% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
100.42%
We have mild expansions while MCHP is negative at -750.85%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-69.23%
Both yoy lines negative, with MCHP at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
33.33%
Buyback growth of 33.33% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.